View printer-friendly version << Back
MEDNAX Announces Acquisition of Pediatric Urology Practice in South Florida

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 2, 2018-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Children’s Urology Associates, P.A., a private pediatric urology practice based in Miami.

Children’s Urology was established in 1999 and employs six physicians, all fellowship trained in pediatric urology, as well as four physician assistants and advanced registered nurse practitioners. The practice provides consult, surgery, cystoscopy, circumcision, ultrasound and urinalysis services to children. It is both office and hospital-based in three counties (Miami-Dade, Broward and Palm Beach), servicing Baptist Children's Hospital, Broward Health Medical Center, Jackson Memorial Hospital, Kendall Regional Medical Center, Joe DiMaggio Children’s Hospital, Nicklaus Children's Hospital and Miami Children’s Ambulatory Surgery Center, West Boca Medical Center and South Miami Hospital. In association with the Nicklaus Children’s Health System and the University of Miami Leonard M. Miller School of Medicine, Children’s Urology participates in the urology residency training program and runs the only Accreditation Council for Graduate Medical Education (ACGME) accredited fellowship training program for pediatric urology in Florida.

“Partnering with MEDNAX’s national network provides a unique opportunity to continue to grow our practice in South Florida and solidify our position in an ever-changing and complex health care environment,” said Rafael Gosalbez, M.D., who will serve as medical director for the practice. “MEDNAX has previously invested locally in pediatric urology, which will facilitate the coordination of care for pediatric patients with the most complex urological disorders. Additionally, MEDNAX has a proven record on outcomes research, and we plan to continue and enhance our own research and educational efforts through this valuable partnership.”

This acquisition adds to the services MEDNAX provides in Florida through its affiliated network of physicians across multiple specialties which include anesthesiology, maternal-fetal medicine, neonatology, newborn hearing screens, obstetric hospitalist, pediatric cardiology, pediatric hospitalist, pediatric intensive care and radiology.

This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

With this acquisition, four physician group practices have become part of MEDNAX in 2018.


MEDNAX, Inc. is a national health solutions partner based in Sunrise, Fla. comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of approximately 4,075 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175 ext. 5692
Vice President, Strategy and Investor Relations